Complications associated with chemotherapy in testicular cancer management
Authors:
- 15 March 2011
- journal article
- review article
- Published by Springer Nature in Nature Reviews Urology
- Vol. 8 (4) , 213-222
Abstract
Testicular cancer is one of the most curable neoplasms and mainly affects young men, meaning that complications arising from its treatment can have long-term effects. In this Review, the authors discuss the various types of adverse effects associated with chemotherapy treatment of testicular cancer, considering the etiologies of these conditions, and possible strategies for their prevention and management. Testicular cancer is the most common solid tumor among men aged 15–35 years. The introduction of cisplatin-based chemotherapy has resulted in a cure rate of over 95% for men with testicular cancer, which has put increased emphasis on understanding the morbidity associated with chemotherapy. Hematological, gastrointestinal, gonadal, otological, renal, neurological, and pulmonary toxicities are the most common acute adverse effects. Although most patients recover, some of these effects can persist after the chemotherapy regimen has been completed and can become chronic problems. The late complications associated with cisplatin-based chemotherapy include secondary malignancies, cardiovascular disease, avascular necrosis, and cognitive impairment. Late complications can have considerable effects on survival and quality of life, so close monitoring of patients is critical for the early diagnosis of late adverse effects and to limit associated damage. All patients should adopt a healthy lifestyle and follow age-appropriate cancer screening programs. Hormonal supplementation should be considered for those with a low testosterone level, in order to reduce the risk of sexual dysfunction and metabolic syndrome. Prompt diagnosis of avascular necrosis is essential, and it should be considered in the differential diagnosis for any long-term testicular cancer survivor complaining of hip pain. Finally, sperm cryopreservation should be discussed with all patients before chemotherapy is initiated.Keywords
This publication has 136 references indexed in Scilit:
- Testicular Cancer Survivorship: Research Strategies and RecommendationsJNCI: Journal of the National Cancer Institute, 2010
- Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer SurvivorsJNCI: Journal of the National Cancer Institute, 2009
- Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancerActa Oncologica, 2008
- Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional studyJournal of Translational Medicine, 2007
- HYPOGONADISM AND METABOLIC SYNDROME: IMPLICATIONS FOR TESTOSTERONE THERAPYJournal of Urology, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Long-Term Complications of Chemotherapy for Germ Cell TumoursDrugs, 2003
- Young age and the risk for ifosfamide-induced nephrotoxicity: a critical review of two opposing studiesPediatric Nephrology, 2001
- Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatinEuropean Journal of Cancer, 1996
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987